Open access peer-reviewed chapter

Analysis of Trends and Challenges of Public Open Data in Health Care Industry Using Artificial Intelligence

Written By

Vijayalakshmi Kakulapati

Submitted: 23 January 2023 Reviewed: 15 May 2023 Published: 07 June 2023

DOI: 10.5772/intechopen.1001885

From the Edited Volume

New Trends and Challenges in Open Data

Vijayalakshmi Kakulapati

Chapter metrics overview

66 Chapter Downloads

View Full Metrics

Abstract

Understanding the public open data being gathered and analyzed is necessary before we can discuss health data analytics and its function in the healthcare industry. A significant quantity of health data is also being obtained, kept, and analyzed, in addition to data on the operations and procedures of the commercial side of the healthcare industry. Any information about a patient’s or a population’s health is referred to as “health data.” Medical professionals and administrators may find areas that need improvement or are in danger by using data from the health industry. With this knowledge, they may take steps to improve any areas where patient care is deficient and elevate the standard of care for all patients. Lab findings, vital sign recordings, prescription diaries, and computerized medical records all include enormous amounts of data. A change in the patient’s health or the possibility of experiencing a major consequence may be detected by physicians and nurses using artificial intelligence (AI) techniques to spot data trends. Due to the complexity and expansion of data in the healthcare sector, AI will be employed there with greater frequency. Numerous types of AI are already being utilized by health insurance companies, medical organizations, and biological sciences enterprises. Solutions can be put into three main categories: operational tasks, patient engagement and participation, and medication and diagnosis recommendations. The health sector uses AI and data engineering to improve the processing and analysis of health data, compensation settlements, and other clinical records. The objective of this chapter is to learn about the capabilities of AI in using public open data as well as the trends and challenges in patient data.

Keywords

  • AI
  • health care
  • data
  • trends
  • challenges
  • patient
  • application
  • algorithms

1. Introduction

This chapter outlines the principles of open data, especially open health data, and examines how these concepts connect to the field of health care. The idea of open data has broad applications across many industries, and the literature that has been written about it emphasizes its significance. Governments from all over the globe are already developing regulations to improve data transparency by laying out in-depth guidelines for how to handle information about the general welfare. Making this data freely accessible to the public in forms that support a range of purposes is becoming more important.

All types of data that are made freely accessible to the public are collectively referred to as “open data” under this broad heading. Information on public health ought to go under this heading. Instead of using personal health information, which, if published incorrectly, might breach someone’s privacy, public health statistics are often aggregated data that could help in making decisions regarding health-related issues. The benefits and gains that might come from having enough information to make decisions are evidence of the need for readily available public health statistics.

Public health data that is documented and publicly accessible may aid in averting disasters. With a focus on open-source application development and code sharing, a rising number of individuals are advocating for data transparency. In the technology context, the concept of openness has notably gained strength. The need for open access to academic content produced by the scientific community has prompted the establishment of a few initiatives [1]. Government organizations throughout the globe are also developing strategies to improve public use and access to government data [2].

The idea of big data has evolved with the open data movement in the healthcare industry. Offering tailored treatment to people, producing early warnings for pandemics, and assisting health system management are just a few of the potential benefits open data platforms bring.

Several sources provide open data on health, including census information, results of surveys on the economy, labor, and education, as well as meteorological information. In addition, on health data files are available on websites such as data.gov, academic journal websites, institutional websites, websites for United Nations agencies, and general-purpose websites [3].

Open data’s perspective for improving public health [4].

  • Enhances analytical and scientific studies capabilities

  • Enhances earlier-than-usual detection and prevention of health and safety risks

  • Enhances alternative assessment and monitoring of valid reactions

  • Enhances capabilities for increased transparency

  • Enhances evaluation capacity and quality measures

  • Enhances early surveillance of the environment and wellness risks

  • Enhances earlier-than-normal tracking for health allegations.

Enormous resources are needed to shift databases toward becoming open, interoperable, and accessible via common protocols and vocabularies. As opposed to the mere fact that single databases can be used more widely, the capacity to use, exchange, and combine this data with other data is the actual value of open data. A cultural change is also required to move away from the concept of databases as proprietary intellectual property and toward the idea of data as a public good.

With more reliable and accessible data, AI is projected to be a major factor behind analytics, insights, and the decision-making procedure. As a result, oanizations that use AI to change their products and services to increase consumer engagement are likely to enjoy quick returns and sustainable strategic superiority [5].

  • The top goals for healthcare firms using AI are to increase process efficiency, improve current goods and services, and reduce costs.

  • The expense of the techniques, incorporating AI into the business, and implementation obstacles, including AI hazards and data issues, were cited as the top concerns concerning risks with AI by healthcare organization respondents.

Health systems were overburdened by the current epidemic, which also revealed their shortcomings in terms of providing treatment and controlling expenses. Because of the need and regulatory flexibility, virtual health underwent a historic transition beginning in March 2020. As health systems, health plans, and PBMs develop their new AI investment strategies, analyzing how healthcare companies utilized artificial intelligence (AI) in the aftermath of the pandemic will continue to be helpful. Although the study was carried out before the public health emergency, some of the lessons are still relevant today.

The following are the main characteristics of AI systems:

  • AI (artificial intelligence) systems might be able to do a better job than regular computer systems.

  • Their fundamental abilities are comparable to human intelligence. Examples of effective patterns include classification, anomaly detection, regression, and prediction.

  • The application of these talents to data sets and problems that are far larger.

  • More complex than those that people can handle is what distinguishes artificial intelligence (AI) from other technologies as a whole.

The widespread usage of artificial intelligence (AI) and digital gadgets is rife with challenges, including issues with privacy [6, 7], cybersecurity, data integrity, ownership, and sharing. Ethical issues are challenging to overcome in the healthcare industry since AI technology has the potential to compromise patients’ autonomy, security, and privacy [8]. The rate of AI development now lags behind the policies and moral guidelines for healthcare services that use AI and its applications.

Public open data advantages

  • Enhances accountability and transparency

  • Building credibility and reputation

  • Growth and innovation

  • Increased perception and community involvement

  • Knowledge is stored and preserved throughout time

The chapter is structured as depicted below. An assessment of the related topic research is presented in Section 2. POD (public open data) in medicine is discussed in Section 3. Section 4 examines the advantages and disadvantages of using free public data when using AI-based technology. Finally, Section 5 discusses challenges and trends in using AI technologies in healthcare data, followed by concluding remarks with future enhancement.

Advertisement

2. Related work

According to several recent studies, AI is capable of and even superior to, performing critical healthcare tasks such as disease diagnosis. Computers are already better than radiologists at spotting malignant tumors these days, and they can also provide researchers advice on how to create cohorts for costly clinical studies. For many reasons, we do not anticipate that AI will ever totally replace people in the context of large-scale medical processes. In this article, we address the opportunities for AI to improve processes related to providing care and some of the barriers preventing AI from being quickly adopted in the health sector [9].

Current advancements in AI applications for drug design and development suggest that DL approaches in models are becoming more popular. Deep-learning models need substantially more time to train than simpler machine-learning methods do because of the size of the training datasets and the sometimes large number of parameters needed. This might be a serious disadvantage when data is hard to come by. As a result, attempts are being made to reduce the amount of data required for training sets for DL so that it may learn new knowledge using just moderate amounts of current data. This is similar to the human brain learning process and would be helpful in cases where large datasets are scarce, and data collection is time- and resource-consuming, as is often the case with medicinal chemistry and novel drug targets. One-shot learning, lengthy short-term memory, and memory-improving neural networks like the differentiable neural computer are just a few of the novel strategies being investigated [10].

The implementation of various websites, open information repositories like GitHub, or open data portals like Kaggle.com may play a crucial role in AI endeavors. Although making open data alone accessible may help larger companies more since they have access to proprietary datasets to combine with open data sources while smaller companies do not, larger companies may still gain from making open data alone accessible. However, depending on the goals of the data analysis and AI applications, the commercial value would mostly come from fusing this open data with specialized data, such as those originating from the firm itself or obtained through internal operations of the organization or networks. Pushing governments to make the data these systems depend on accessible is one strategy to promote data accessibility and enhance data quality. Many governments rely on algorithms and AI systems to provide public services. There must be a substantial quantity of high-quality data accessible for AI systems to be taught, which is not necessarily the case in all nations [11].

Utilizing this cutting-edge technology makes managing medical care more effective. Because there are benefits to using AI in healthcare, the future is not all upbeat. The appropriate law is not yet fully prepared for this breakthrough, and there are several worries about how AI may operate in terms of doctors’ rights and obligations and protect privacy issues. Nevertheless, current laws favor AI, as seen by its application in the global healthcare system. The guidelines for developing technology and health technology goods may be established and used in medical care, as has been shown [12]. This research sought to identify the potential benefits and dangers of AI in the healthcare industry.

Advertisement

3. About public open data in healthcare

Openness may mean various things to different people and organizations, although the phrase “open data” sounds self-explanatory. In addition, there may be notions and principles that only apply to certain industries. For instance, open data must be maintained after it has been distributed, according to the Project Open Data of the United States of America [13]. Although they are often only obligated to store the data for a short while after the project is over, this concept also applies to academic research initiatives.

Large databases of patient data have been amassed since the advent of EMRs, and when taken as a whole, they may be utilized to spot healthcare patterns within various illness areas. Laboratory test results, medical pictures, clinical narratives, and records of diagnoses and actions are all included in the EMR databases. Building prediction models from all this information may assist physicians with diagnosis and other therapeutic decision-making processes. It will be feasible to extract a variety of data, including correlations between past and present medical occurrences and information about connected illness consequences, as AI capabilities develop [14]. The patient may be healthy or not be exhibiting any symptoms while the data is absent, yet it is often missing from hospital visits and data collected between therapies. Such data may be utilized to develop an end-to-end model of both “health” and “disease,” to study long-term effects and develop new sickness categories.

Unclean and Disturbed Information Additionally, data may be noisy and inaccurate. For instance, the data’s labels or contextual information might be wrong, or the readings themselves could be erroneous. However, the problem of crowdsourcing’s noise has not yet been addressed. Because crowdsourcing relies on human judgment to give labels to data, particularly when used for participatory sensing, it may potentially produce noisy data. Although big data is not the only source of dirty and noisy data, the methods for dealing with it may not be well suited to dealing with massive datasets.

Nowadays, data about various aspects of our lives are obtained in a variety of ways, but the techniques and methods used to collect the data may introduce ambiguity. A machine-learning system finds it challenging to conclude such data because of this lack of impartiality. This inherent unpredictability cannot be eliminated even by the most advanced data preprocessing techniques [15]. Once again, this presents particular difficulties for machine learning with big data.

An AI-based technology for complete EMR data analysis is DeepCare. To acquire and maintain events in the memory unit, it makes use of a DDMNN (deep dynamic memory neural network). The system’s long-term, short-term memory uses a time-stamped series of events to represent user healthcare routines and sickness trajectories, allowing it to identify long-term dependencies [16]. The DeepCare framework can predict illness development, enable intervention advice, and offer disease prognosis based on EMR databases using the stored data. By examining data from a cohort of diabetic and mental health patients, DeepCare was demonstrated to be able to predict the onset of disease, identify the most effective treatments, and estimate the likelihood of readmission.

The capability of machine learning and artificial intelligence may be unlocked via accessibility to POD (public open data). A study using artificial intelligence that is noteworthy demonstrates how a police department that prioritizes crime prevention utilizes large volumes of open data. The computer created patterns to identify “hotspots,” places where certain crimes are expected to occur in the future, based on the instances of crimes (data) and their frequency. These “hotspots” are predetermined geographic locations where the algorithm can make accurate estimations about the kind of crime that could happen and when it is most likely to happen. Various presumptions and trends, such as the fact that cybercriminals often operate in the same location for longer periods, serve as the foundation for these forecasts [17].

Over 80% of the time spent on AI initiatives in India is already spent on data preparation and technical duties. Given the wide variety of demographic, socioeconomic, epidemiological, and climatic conditions, information gathered from these geographies is only marginally useful for informing AI models used in India’s many regions. The utilization of data from countries with established open data programs is a choice made by Indian engineers in various circumstances.

Advertisement

4. Challenges and trends of public open data using AI

4.1 Challenges

In the SAR database, which is maintained by the Institute of Cancer Study, information from scientific research is combined with genetic and clinical data from actual patients. AI may be used to help in the identification of new drugs and to scan the scientific literature for relevant research [18]. The development of drugs has been sped up and made more affordable because of the creation of Eve, an artificial intelligence (AI) “robot scientist” [19]. In order to identify potential novel cancer medication targets, artificial intelligence is used in the Institute of Cancer Research’s SAR database, which integrates genetic and clinical data from patients with data from academic research [17]. In addition, AI systems employed in healthcare might benefit medical research by assisting in matching appropriate individuals to clinical investigations [20].

A key issue for the future of AI governance will be making sure that AI is developed and used in a way that is open to the public, works for the public good, and promotes and speeds up research. Many of the ethical and social concerns highlighted by the use of AI also apply to other uses of data and healthcare technology. AI usage creates a variety of ethical and social concerns.

4.1.1 Finding data

Governments may be making the data public, but that does not always imply it is simple to discover. Governments often lose reliability when they improve their data skills and create better material. As a result, it is more complicated for users to locate the information and files they need on the website.

4.1.2 Usage of data

Even though governments are making the data public, that does not imply that it is “ready for use.” There may be variations in format and other compatibility problems. When we compare open data sets across time, they often contain a varied collection of fields. It makes it difficult for consumers to estimate growth in a crucial field for more than 3 years [21].

4.1.3 Quality of data

Clinics must also deal with difficulties related to adequate collection and usage of data for continuous improvement and discrepancy minimization. In a survey that was conducted by the National Public Health and Hospitals Institute (NPHHI) in 2006, hospitals that collected racial and ethnic data were asked if they used the data to assess and compare the quality of care, the use of medical services, or patient satisfaction across their various patient populations. They were used by fewer than one in five hospitals for any of these purposes [22, 23].

4.1.4 Claims-related and managerial

In addition to clinics and insurance providers, the bulk of the data comes from federal, state, and local government agencies. Documentation of payments made by insured people to the healthcare system or summaries of hospital discharges may be included [24]. The phrase “produced in a clinical environment and supervised by a doctor” refers to a wide variety of data kinds [25].

Repositories and the findings of clinical investigations with public and commercial funding are examples of data. In the course of a clinical study, a lot of data is produced that contains personal information about patients. To acquire and utilize this data, investigators must seek legal authorization.

4.1.5 Electronic health records

(EHRs) may be used by doctors to create customized treatment plans and make diagnoses. To create longitudinal profiles of people and populations, this data may also be integrated with socioeconomic determinants of healthiness. EHR data focuses on specific individuals and may include details on regular visits, treatments, and diagnostic interventions.

Genomic data may include a wide range of features, from whole DNA sequences to specific DNA variations. The development of improved, effective treatments, more effective diagnostic tests, evidence-based methods for proving a clinical success, and better tools for patients and providers to make decisions are already made possible by genome-based research [26]. The whole genomic sequence of an individual may now be analyzed and stored as data [27].

4.1.6 The term “patient-generated data”

It refers to health-related information created and recorded by or from patients outside of a therapeutic setting. Due to the development of wearable health technology and mobile health apps, this sort of data is becoming more and more common. Genomic information is regarded as being very sensitive and should only be exchanged and utilized under strictly regulated circumstances [25].

4.1.7 Data from wearable technology

Such as smartwatches, voice assistants, and mobile software apps, is included in IoT data. These data have the potential to provide crucial details on several vital health markers, including heartbeats and sleep patterns. These innovations are components of the expanding network of machines and gadgets linked to the internet known as the “internet of things,” or IoT.

4.1.8 Data from social media

Covers communications on websites like Facebook and Twitter. It may shed light on perceptions about wellness as well as the connection between a person’s health and their daily lives, according to investigators. Social media data is gathered by “terms of service” contracts, much like IoT data [28].

Health disparities in the demographic health survey relate to “cases in the settings in which people are born, live, learn, and work that affects a wide range of health, functional, and quality-of-life consequences and dangers.” Access to food and housing alternatives, as well as possibilities for education and employment, are a few examples of these social determinants [29]. Data on social determinants of health may be obtained from a variety of sources, both within and outside of government, and utilized to improve healthcare quality.

According to the US Department of Health and Human Services, data is the “continuous, systematic collection, analysis, and interpretation of health-related data vital to the planning, implementation, and assessment of public health practices” (HHS) [30].”

When humans use artificial intelligence to uncover similarities in genetic data versus very private patient history data, they face comparable difficulties with data presentation and perspective. Fractal representation and even statistical patterns are incredibly challenging concepts for people to grasp. The computer will be able to characterize anything we observe that has a statistical quality, but we can too [31].

The use of AI to enhance healthcare now faces several challenges for investigators and clinicians. Access control restrictions, data governance issues, and ethical data usage are a few of them.

High-quality, accurate, and clean data are essential to artificial intelligence. Large amounts of health data, including those from wearable technology and sensors as well as electronic health records (EHRs), are now being mined by researchers [32]. Future uses of disruptive AI will be made possible by the healthcare system’s increased connectivity and interoperability of data.

In the area of digital forensics, there is a severe lack of professionals. A novel strategy is required because of the rising demand. The solution to this demand gap may be found in artificial intelligence. It can decipher data presented as either an image or a video.

The data produced by clinical procedures, including medical examinations, diagnostics, therapy assessments, and other similar clinical activities, must first be “trained” into AI systems before they can be utilized in healthcare systems. This enables them to recognize subject groupings that are comparable to one another and establish relationships between subject characteristics and desired results. These clinical data often take the form of demographic information, medical records, electronic recordings from medical equipment, physical examinations, clinical laboratory findings, and photos, but they are not just these [33].

A further issue is the dissemination of information. Clinical trial data must be frequently used to train AI systems if they are to work successfully. Maintaining the data source, however, becomes a critical challenge for the system’s continuing development and improvement whenever an AI system is placed into service after its first training on historical data. Incentives for exchanging system data are currently missing from the healthcare perspective. However, the US healthcare industry is undergoing a transition that will encourage data sharing. A new payment system for health services [34] is where the reform process begins. Numerous payors—mostly insurance companies—have switched from compensating doctors by changing the amount of their patient care to rewarding them for the quality of their care.

In the past, personal health records have often lacked patient-related functions and have been more physician-focused But a patient-centered personal health record is a must if we want to encourage people to take care of themselves and improve patient outcomes. While giving professionals more time to focus on more pressing and important responsibilities, the aim is to give patients more independence to control their diseases.

A healthcare AI algorithm’s development requires a specialized dataset, which presents a challenge. Because of this, the resulting data model may not precisely represent local patient data. In addition, the clinical and ethical concerns in various medical specialties, like radiology or pediatrics, vary, so it is important to analyze the dangers of AI in the context of each relevant area [35].

Designing new, safe computer system ecosystems and rethinking how we perceive privacy and control is also necessary for data security in massively dispersed infrastructures. Large datasets with high noise are a significant issue that calls for novel analytics techniques. The amount of resilience required by the techniques now in use leads to errors and the production of false positive signals [36].

A challenge arises when research findings from huge databases are utilized to select user-served persons and disease regions for treatments before the availability of scientific proof. Providing sample data that is accessible to the public might give hackers access to vulnerable AI models. Attacks may exploit data poisoning when open datasets are generated by the public or subject to public updates. In one research study, the danger posed by adversarial assaults that slightly alter pictures for medical imaging software was investigated. Although these changes were not evident to the human eye, deep learning algorithms may nonetheless misclassify images up to 100% of the time [37]. This kind of attack may have severe ramifications since several organizations, including government organizations, provide public databases of medical images to assist in diagnosis and treatment [38].

The majority of individuals believe that AI technology will enhance and assist human labor rather than replace physicians and other care providers. AI is ready to help healthcare personnel with a variety of tasks, including administrative operations, clinical notes, and patient engagement. Additionally, it may provide specific assistance in patient monitoring, picture analysis, and the automation of medical devices.

The challenge of monitoring in compartmentalized EHRs may be resolved by using AI techniques, which will reroute such reports to analysis and predictive modeling. Programs for preventive healthcare may also use this technology. For example, it may integrate data from various data sources, such as electronic health records (EHRs), with a person’s omic (genome, proteome, metabolome, and microbiome) data to predict the likelihood of getting a disease [39].

Utilizing AI to assess clinical information, scholarly publications, and ethical standards may help in making decisions about the treatment to provide patients [40].

4.2 Trends

Each year, thousands of hospital patients experience avoidable suffering and death as a result of medical mistakes. These mistakes are often caused by doctors handling a heavy caseload with insufficient medical histories. Faster than most medical practitioners, AI can forecast and diagnose illnesses. Incorporating AI into EHR software has been a gradual process for companies [41].

4.2.1 AI in administration

For the handling of administrative data, many healthcare companies are turning to AI. AI can speed up and reduce error rates in a variety of administrative tasks, including insurance processing, clinical notes, management of revenue cycles, healthcare document management, and some other administrative functions. Utilizing AI solutions to identify and correct code defects and false claims might result in significant attention, revenue, and manpower savings for these businesses.

4.2.2 Drug discovery and AI

In terms of drug research and clinical development, AI represents a paradigm shift. The discovery process may be sped up significantly by utilizing AI’s effectiveness, precision, and rate of data processing. Depending on the medicine class, just the clinical studies themselves might cost millions of dollars. Even after the clinical testing stage, only 10% of medications reach the market.

4.2.3 AI for healthcare and robotic surgery

Robotic surgical suites driven by AI provide clinicians with a high level of accuracy, flexibility, and control than they would otherwise have. Robot-assisted operations, therefore, result in fewer surgical problems, reduced postoperative discomfort, and quicker recovery durations. Even future doctors will be trained with surgical robots.

4.2.4 Biassed data

Several factors, such as social prejudice (inaccessibility to healthcare) and small populations (for instance, minority communities), might lead to the existence of data that is not reflective [42]. For the AI model’s training, a sizable quantity of information regarding health data or other topics is needed.

4.2.5 Organ care improvement

One way to increase organ care is to take care of the organ while it is outside the body. In addition, machine learning may allow for a more precise evaluation of a preserved organ’s transplant ability. If this could be found more quickly, lives could be saved more quickly.

4.2.6 Bioprinting

Other alternatives should be investigated besides keeping organs alive outside the body; although they seem like science fiction, 3D-printed organs are a very real, still emerging technology that has already entered clinical testing. Clinical trials for 3D bioprinting of bones, skin, corneas, ears, and other organs are underway.

The method of developing a digital organ model that can be printed out is called bioprinting. Bioink, which is made of live cells, is the ink used in printing. By analyzing organ and patient traits using AI, it is possible to better design organs to be compatible with their new hosts. In every way, medical technology will develop. Threats always evolve and must be dealt with via prevention rather than response, despite industry-wide security advancements.

4.2.7 Data privacy protection

The main foundation upon which DL and ML models are formed is the availability of data and resources to train these models. Given that this data is generated by millions of individuals throughout the globe, there is a chance that it may be abused. In other firms, creative efforts to overcome these challenges have already started. On smart devices, the data is used to train the model, and only the trained model is delivered, with no training data being sent back to the servers [43].

4.2.8 Limited data

AI heavily relies on data, and annotated data is used to teach computers to understand and predict. Numerous companies are putting their attention toward developing artificial intelligence (AI) solutions that can provide reliable results in the absence of data. The whole framework might become unreliable due to inaccurate data.

4.2.9 Regulatory concerns that arise with AI

Regarding the use of AI in medicine, there are presently no internationally uniform legislation or regulations [44]. AI crime, a brand-new, harmful crime, might happen if criminals employ AI [45]. Legal professionals cannot create such laws on their own. Participants interested in the implementation of AI-based treatment modalities must be addressed [46].

4.3 Medical industry developments including AI

  • Healthcare AI,

  • Telemedicine,

  • Remote treatment development,

  • Augmented awareness in healthcare environments,

  • Bioprinting and innovation for organ care,

  • Smart and IoT in Healthcare,

  • Healthcare data protection.

Another challenge is the limitation of intent [47]. Data may be used for purposes other than those for which they were intended if copyright rules are not drafted properly [48]. Regarding the repercussions of decisions taken by automated decision-making systems, authorities must be clear about who is responsible for implementing AI [49].

In terms of data availability and value, open source presents unique issues. Transparent and excellent datasets are not always a result of open-source technologies. To understand the idea of accessibility, the whole open-source ecosystem must be taken into account. There is still a lack of transparency on how AI quality can be evaluated when using open-source AI software on “closed data.” Consequently, the potential advantages of open source are hampered since not all components connected to AI are open source. Adopting standard protocols is essential to achieving true transparency.

Due to its capacity to promote openness and accountability in government, open data may help address some of these issues. If these programmers are volunteers, they are allowed to leave the project anytime they choose, which might impede its growth since the work’s quality and productivity rely on continued developer engagement. The decentralized AI strategic plan is one potential solution to address issues related to data confidentiality and risks while keeping open sources.

Technology for patient care support may increase physicians’ workload and promote the mobility and health of patients. For instance, remote medical assistants may suggest different exercise routines or remind people to take their prescribed drugs at certain times. In addition, patients will have remote access to the gadget and be able to view their biometric data while still feeling as if communicating with a kind and sympathetic system.

To aid patients with lifting and transporting heavy objects, the RIBA assistive robot—named for its human-like arms—was created. The use of tactile sensors or tactile guidance to explain instructions to RIBA is also an option. Robotic patient transfer from a bed to a wheelchair and vice versa is possible [50].

The patient can provide as much information as they want in text, photographs, audio, and video. This enables the doctor to examine and evaluate the data before speaking with the patient. This is quite inspiring and inventive, considering how many individuals do not have the time or money to visit a doctor.

4.4 Advantages of AI in healthcare data

4.4.1 Information access

Providing quality data in real-time is one of artificial intelligence’s stronger points in the health sector. Faster diagnosis based on the findings is made possible, which significantly positively impacts patients’ chances of recovering or following their treatment plan. Medical practitioners may also get real-time information on the status, crises, and changes that the patient may have experienced via smartphone notifications.

4.4.2 Challenge optimization

AI has helped the healthcare sector simplify a lot of work, including scheduling visits and transferring patient information and medical histories. Radiotherapy uses advanced analytics that can even intuitively pick out key signs. This makes it faster to look at diseases in depth.

4.4.3 Expenditure and insight

The costs of clinics might be significantly lowered when AI replaces laborious human work with sophisticated algorithms. Certain AI can also help with evaluations to provide an analysis of what the clinic requires.

4.4.4 Investigative competence

AI may incorporate different information sources based on the study, which can be very useful for assessing illnesses, other than supplying real-time data. To aid in the essential processes and alternatives per developmental stage, software to treat certain major illnesses has been developed.

Advertisement

5. Discussion

The potential for releasing healthcare data and sharing large datasets is immense, but significant obstacles and hurdles exist. Data visibility issues and a lack of connections between individuals and organizations working to tackle comparable issues are significant hindrances to global development. Nevertheless, collaboration would be accelerated, and some of the largest problems in global health would be resolved via a sustained open data revolution. Other difficulties include combining the need to promote innovation with ensuring that AI development and usage are open, responsible, and consistent with the public interest. Numerous people have stressed the need for academics, medical practitioners, and policymakers to have the abilities and expertise to assess and use AI to its fullest potential [51].

Effective health treatment choices and outcomes are only one benefit of using medical technology. Additional benefits might include reduced admissions, cheaper costs, and much more effective provision of resources. It may also assist local health centers and entice patients to live and operate therein. A further equal universal medical system may result in the end [52]. Boosting quick acceptance, sustainable implementation in the health system, a lack of respect for user perspectives, and the impossibility of automation being utilized to its complete capacity without the adoption of AI in the public health sector are the challenges. A foundation for future studies on many facets of digital innovation in the health sector is provided by the usage of AI in health service [53].

Advertisement

6. Conclusion

Several adjustments would need to be made to use open data in the healthcare system fully. The most basic one would be a move to data-driven techniques in health and care, where medical choices regarding treatment are based on data from thousands of individuals. The full potential of open data in healthcare is also hindered by organizational and technological issues, such as the difficulty of many healthcare data systems to provide consistent data. Finally, owing to the repercussions of improper handling of medical data, privacy and confidentiality are issues. Nevertheless, understanding, controlling, and reducing the consequences of health issues on people, society, and the economy depends on data.

The issues and challenges include stimulating early acceptance, long-term deployment in the healthcare system and disregard for the viewpoint of the user. Despite not being exploited to its full potential, technology is essential for the advancement of artificial intelligence in the medical sector. Developing new approaches to a healthy alignment involves identifying innovative ways to meet corporate needs and effectively involve the public. Large-scale integration and accessible data access for scientific purposes while protecting privacy rights.

Advertisement

7. Future enhancement

In the future, we will focus on analyzing data infrastructure, effective information exchange and integration, and efficient data release in open and machine-readable forms. The fact that there is a different balance between privacy and openness adds to the difficulty of mitigating the danger of re-identification of quality data. As public-private data collaborations become more significant, it is crucial to make sure that these initiatives promote equitable growth. Although the data protection and privacy regulations only make up a small portion of a country’s overall data governance system, they often get the most attention since they deal with politically touchy subjects. In this chapter, we discussed the various trends and challenges of open data, as well as how AI technologies use these data. Using public open data, we will create some AI real-time applications.

References

  1. 1. Stebbins M. Expanding Public Access to the Results of Federally Funded Research. Available from: https://www.whitehouse.gov/blog/2013/02/22/expanding-public-access-results-federally-funded-research
  2. 2. Sheehan J. Increasing Access to the Results of Federally Funded Science. Available from: https://obamawhitehouse.archives.gov/blog/2016/02/22/increasing-access-results-federally-funded-science
  3. 3. Available from: https://globalhealthdata.org/opening-health-data-to-the-public
  4. 4. Huston P, Edge VL, Bernier E. Reaping the benefits of Open Data in public health. Canada Communicable Disease Report. 2019;45(11):252-256. DOI: 10.14745/ccdr.v45i10a01
  5. 5. Available from: https://www2.deloitte.com/us/en/insights/industry/health-care/artificial-intelligence-in-health-care.html
  6. 6. Safavi K, Kalis B. How AI can change the future of health care. Harvard Business Review. 2019. Available from: https://hbr.org/webinar/2019/02/how-ai-can-change-the-future-of-health-care
  7. 7. Yoon S, Lee D. Artificial intelligence and robots in healthcare: What are the success factors for technology-based service encounters? International Journal of Healthcare Management. 2019;12:218-225
  8. 8. Rigby M. Ethical dimensions of using artificial intelligence in healthcare. AMA Journal of Ethics. 2019;21:E121-E124
  9. 9. Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Future Healthcare Journal. 2019;6(2):94-98. DOI: 10.7861/futurehosp.6-2-94
  10. 10. Lavecchia A. Deep learning in drug discovery: Opportunities, challenges, and future prospects. Drug Discovery Today. 2019;24(10):2017-2032
  11. 11. Theben A, Gunderson L, López Forés L, Misuraca G, Lupiáñez Villanueva F. Challenges, and limits of an open source approach to Artificial Intelligence, study for the Special Committee on Artificial Intelligence in a Digital Age (AIDA), Policy Department for Economic, Scientific, and Quality of Life Policies. Luxembourg: European Parliament; 2021
  12. 12. Faridah L, Rinawan FR, Fauziah N, Mayasari W, Dwiartama A, Watanabe K. Evaluation of Health Information System (HIS) in The Surveillance of Dengue in Indonesia: Lessons from Case in Bandung, West Java. Int J Environ Res Public Health. 10 Mar 2020;17(5):1795. DOI: 10.3390/ijerph17051795
  13. 13. Project Open Data Principles. Available from: https://project-open-data.cio.gov/principles/
  14. 14. Pham T, Tran T, Phung D, Venkatesh S. Predicting healthcare trajectories from medical records: A deep learning approach. Journal of Biomedical Informatics. 2017;69:218-229
  15. 15. Hausenblas M, Jacques Nadeau J. Apache Drill Adhoc interactive analysis at scale. Jun 2013. DOI: 10.1089/big2013.0011
  16. 16. Pham T, Tran T, Phung D, Venkatesh S. DeepCare: A deep dynamic memory model for predictive medicine. In: Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). Springer; 2016
  17. 17. Available from: https://data.europa.eu/en/publications/datastories/ai-and-open-data-crucial-combination
  18. 18. O’Mara-Eves A et al. Using text mining for study identification in systematic reviews: A systematic review of current approaches. Systematic Reviews. 2015;4:5
  19. 19. The Conversation (11 November 2013) Artificial Intelligence uses the Biggest Disease Database to Fight Cancer
  20. 20. Williams K et al. Cheaper faster drug development validated by the repositioning of drugs against neglected tropical diseases. Journal of the Royal Society Interface. 2015;12:20141289
  21. 21. Alder Hey Children’s NHS Foundation Trust. 2016. Alder Hey Children’s Hospital is set to Become UK’s First ‘cognitive’ Hospital
  22. 22. Regenstein M, Sickler D. Race, Ethnicity, and Language of Patients: Hospital Practices Regarding the Collection of Information to Address Disparities in Health Care. Princeton, NJ: Robert Wood Johnson Foundation; 2006
  23. 23. Hasnain-Wynia R, Pierce D, Pittman MA. Who, When, and How: The Current State of Race, Ethnicity, and Primary Language Data Collection in Hospitals. New York: The Commonwealth Fund; 2004
  24. 24. University of Washington Health Sciences Library, “Data Resources in the Health Sciences”. Available from: http://guides.lib.uw.edu/hsl/data/findclin
  25. 25. Office of the National Coordinator for Health Information Technology, Conceptualizing a Data Infrastructure for the Capture, Use, and Sharing of Patient-Generated Health Data in Care Delivery and Research through 2024, 2018. Available from: https://www.healthit.gov/sites/default/files/onc_pghd_final_white_paper.pdf
  26. 26. National Institutes of Health National Human Genome Research Institute, “A Brief Guide to Genomics”. Available from: https://www.genome.gov/about-genomics/fact-sheets/A-Brief-Guide-to-Genomics
  27. 27. PHG Foundation at the University of Cambridge, Identification and Genomic Data, 2017. Available from: http://www.phgfoundation.org/documents/PHGF-Identification-and-genomic-data.pdf
  28. 28. Padrez K et al. Linking social media and medical record data: A study of adults presenting to an academic, urban emergency department. BMJ Quality & Safety. 2016. DOI: 10.1136/bmjqs-2015-004489
  29. 29. Office of Disease Prevention, and Health Promotion, “Social Determinants of Health”. Available from: https://www.healthypeople.gov/2020/topics-objectives/topic/social-determinants-of-health
  30. 30. World Health Organization, “Public Health Surveillance”. Available from: https://www.who.int/topics/public_health_surveillance/en/
  31. 31. Available from: https://emerj.com/ai-sector-overviews/healthcare-ai-use-cases-and-trends-an-executive-brief
  32. 32. Ismail N. The success of artificial intelligence depends on data. Information Age. 2018. Available from: https://www.information-age.com/success-artificial-intelligence-data-123471607/
  33. 33. Available from: https://www.federalregister.gov/documents/2013/09/18/2013-22645/guidance-for-industry-on-electronic-source-data-in-clinical-investigations-availability
  34. 34. Kayyali B, Knott D, Kuiken SV. The Big-data Revolution in US Health Care: Accelerating Value and Innovation. 2013. Available from: http://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/thebig-data-revolution-in-us-health-care
  35. 35. Available from: https://www.computerweekly.com/news/252524829/The-challenges-of-verifying-AI-for-healthcare
  36. 36. Havens JC. Artificial Intelligence is Doomed if We Don’t Control our Data. 2014. Available from: http://mashable.com/2014/09/16/artificial-intelligence-failure/
  37. 37. Choi CQ. Medical imaging AI software is vulnerable to covert attacks. IEEE Spectrum. 2018
  38. 38. Kent J. NIH makes the largest set of medical imaging data available to public. HealthITAnalytics. 2018
  39. 39. R. Eubanks, 2017, Artificial Intelligence and the Healthcare Ecosystem – Part One. Available from: https://www.capgemini.com/2017/10/artificial-intelligence-and-thehealthcare-ecosystem-part-one/. [Accessed: January 5, 2018]
  40. 40. Dilsizian SE, Siegel EL. Artificial intelligence in medicine and cardiac imaging. Current Cardiology Reports. 2013;16:441
  41. 41. Future Advocacy. Ethical, Social, and Political Challenges of Artificial Intelligence in Health. 2018. Available from: https://taazaa.com/healthcare-ai-trends/
  42. 42. Akmal A, Greatbanks R, Foote J. Lean thinking in healthcare – findings from a systematic literature network and bibliometric analysis. Health Policy (New York). 2020;124:615-627. DOI: 10.1016/j.healthpol.2020.04.008
  43. 43. Available from: https://www.upgrad.com/blog/top-challenges-in-artificial-intelligence/
  44. 44. Mitchell C, Ploem C. Legal challenges for the implementation of advanced clinical digital decision support systems in Europe. Journal of Clinical and Translational Research. 2018;3:424-430
  45. 45. King TC, Aggarwal N, Taddeo M, et al. Artificial intelligence crime: An interdisciplinary analysis of foreseeable threats and solutions. Science and Engineering Ethics. 2020;26:89-120
  46. 46. Cath C. Governing artificial intelligence: Ethical, legal and technical opportunities and challenges. Philosophical Transactions of the Royal Society A. 2018;376:20180080
  47. 47. Available from: https://mobidev.biz/blog/technology-trends-healthcare-digital-transformation
  48. 48. Finland AI. 3 Eleven Key Actions Ushering Finland into the Age of Artificial Intelligence. AI Finland; 2019
  49. 49. Lee J. Government policy toward open-source software: The puzzles of neutrality and competition. Knowledge, Technology, & Policy. 2006;18:113-141
  50. 50. Sweden AI. Decentralized AI. AI Sweden; 2021
  51. 51. Joseph A, Christian B, Abiodun AA, Oyawale F. A Review on Humanoid Robotics in Healthcare. MATEC Web of Conferences; 2018. Available from: https://www.matec-conferences.org/
  52. 52. Available from: https://www.openaccessgovernment.org/what-are-the-pros-and-cons-of-implementing-ai-in-healthcare/140058
  53. 53. Powles J, Hodson H. Google DeepMind and healthcare in an age of algorithms. Health Technology. 2017;7:351-367

Written By

Vijayalakshmi Kakulapati

Submitted: 23 January 2023 Reviewed: 15 May 2023 Published: 07 June 2023